{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:00:38Z","timestamp":1794258038543,"version":"4.9.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["13\/179\/01"],"award-info":[{"award-number":["13\/179\/01"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Fecal microbiota transplantation (FMT) is a promising therapy for ulcerative colitis, but variable responses and unclear mechanisms limit its efficacy. We aimed to compare nasogastric versus colonic FMT delivery and define the microbial and immunological changes associated with clinical response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, open-label, randomized pilot trial (STOP-Colitis), 30 adults with active ulcerative colitis were randomized to receive multidose FMT via nasogastric tube or colonoscopy with subsequent enemas. Key endpoints were clinical outcomes at week 8 and longitudinal multi-omic analyses of stool and biopsies to define changes in microbial composition (16S rRNA and shotgun metagenomics), short-chain fatty acids (SCFAs), mucosal T-cells, and host gene expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Colonic FMT was superior to nasogastric delivery, with a higher clinical response rate at week 8 (75% [9\/12] vs 25% [2\/8]; risk ratio 2.94, 95% CI 0.84-10.30\u2014per protocol analysis). Response was underpinned by successful microbial engraftment, leading to significantly increased fecal microbial diversity and enrichment of SCFA-producing taxa, including Oscillospiraceae and Christensenellaceae. This correlated with reduced fecal calprotectin. Responders showed a significant increase in mucosal regulatory T cells (P\u2009=\u2009.01), with a concurrent decrease in Th17 (P\u2009=\u20090.03) and CD8+ T cells. This anti-inflammatory shift was confirmed by mucosal transcriptomics, which revealed upregulation of metabolic pathways and downregulation of proinflammatory defense pathways in responders. (Trial registration: ISRCTN74072945).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Colonic FMT is a more effective delivery route than nasogastric administration. Clinical response is driven by the engraftment of immunomodulatory bacteria that restore a healthy host\u2013microbe dialogue, providing rationale for developing targeted microbial therapeutics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjag006","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:22:48Z","timestamp":1768825368000},"source":"Crossref","is-referenced-by-count":8,"title":["Mechanistic insights into fecal microbiota transplantation for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial"],"prefix":"10.1093","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1673-7792","authenticated-orcid":false,"given":"Mohammed Nabil","family":"Quraishi","sequence":"first","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre, University of Birmingham , Birmingham,","place":["United Kingdom"]},{"name":"Department of Gastroenterology, University Hospitals Birmingham , Birmingham,","place":["United Kingdom"]},{"name":"Department of Gastroenterology, Sheikh Shakhbout Medical City, Pure Health , Abu Dhabi,","place":["United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A","family":"Moakes","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Yalchin","sequence":"additional","affiliation":[{"name":"St Mark\u2019s Hospital Department of Gastroenterology, , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Blackwell","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Glasgow Royal Infirmary , Glasgow,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Segal","sequence":"additional","affiliation":[{"name":"St Mark\u2019s Hospital Department of Gastroenterology, , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J","family":"Ives","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2498-8407","authenticated-orcid":false,"given":"Laura","family":"Magill","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Manzoor","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9432-2200","authenticated-orcid":false,"given":"Konstantinos","family":"Gerasimidis","sequence":"additional","affiliation":[{"name":"Human Nutrition, University of Glasgow , Glasgow,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"McMullan","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mathers","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Horniblow","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrushma","family":"Loi","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjinder","family":"Kaur","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Loman","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Infection, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Sharma","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre, University of Birmingham , Birmingham,","place":["United Kingdom"]},{"name":"Department of Gastroenterology, University Hospitals Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hawkey","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"McCune","sequence":"additional","affiliation":[{"name":"South Tees NHS Foundation Trust , Middlesbrough,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Quick","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Infection, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Nicholls","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Infection, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"McMurray","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Infection, University of Birmingham , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Nichols","sequence":"additional","affiliation":[{"name":"Human Nutrition, University of Glasgow , Glasgow,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaios","family":"Svolos","sequence":"additional","affiliation":[{"name":"Human Nutrition, University of Glasgow , Glasgow,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Raguideau","sequence":"additional","affiliation":[{"name":"Organisms and Ecosystems, Earlham Institute , Norwich,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Kerbiriou","sequence":"additional","affiliation":[{"name":"Human Nutrition, University of Glasgow , Glasgow,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye H","family":"Oo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospitals Birmingham , Birmingham,","place":["United Kingdom"]},{"name":"National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Centre for Liver and Gastrointestinal Research , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0784-2967","authenticated-orcid":false,"given":"Andrew D","family":"Beggs","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre, University of Birmingham , Birmingham,","place":["United Kingdom"]},{"name":"National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Centre for Liver and Gastrointestinal Research , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Crees","sequence":"additional","affiliation":[{"name":"Crohn\u2019s and Colitis UK ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-6646","authenticated-orcid":false,"given":"Richard","family":"Hansen","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Dundee , Dundee,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailsa L","family":"Hart","sequence":"additional","affiliation":[{"name":"St Mark\u2019s Hospital Department of Gastroenterology, , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R","family":"Gaya","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Glasgow Royal Infirmary , Glasgow,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Quince","sequence":"additional","affiliation":[{"name":"Organisms and Ecosystems, Earlham Institute , Norwich,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-9882","authenticated-orcid":false,"given":"Tariq H","family":"Iqbal","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre, University of Birmingham , Birmingham,","place":["United Kingdom"]},{"name":"Department of Gastroenterology, University Hospitals Birmingham , Birmingham,","place":["United Kingdom"]},{"name":"National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Centre for Liver and Gastrointestinal Research , Birmingham,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"2026032500120364900_jjag006-B1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"2026032500120364900_jjag006-B2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"2026032500120364900_jjag006-B3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41575-022-00593-y","article-title":"Multiomics to elucidate inflammatory bowel disease risk factors and pathways","volume":"19","author":"Agrawal","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026032500120364900_jjag006-B4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","article-title":"The gut microbiome and inflammatory bowel diseases","volume":"73","author":"Shan","year":"2022","journal-title":"Annu Rev Med"},{"key":"2026032500120364900_jjag006-B5","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1038\/s41591-024-03280-4","article-title":"Noninvasive, microbiome-based diagnosis of inflammatory bowel disease","volume":"30","author":"Zheng","year":"2024","journal-title":"Nat Med"},{"key":"2026032500120364900_jjag006-B6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41575-023-00871-3","article-title":"Neutrophils: from IBD to the gut microbiota","volume":"21","author":"Danne","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026032500120364900_jjag006-B7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","article-title":"Inflammatory bowel diseases (IBD) and the microbiome\u2014searching the crime scene for clues","volume":"160","author":"Lee","year":"2021","journal-title":"Gastroenterology"},{"key":"2026032500120364900_jjag006-B8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cei.13397","article-title":"Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease","volume":"199","author":"Quraishi","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"2026032500120364900_jjag006-B9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2023.09.019","article-title":"Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care","volume":"166","author":"Gilliland","year":"2024","journal-title":"Gastroenterology"},{"key":"2026032500120364900_jjag006-B10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gutjnl-2017-314903","article-title":"Adherent-invasive Escherichia coli in inflammatory bowel disease","volume":"67","author":"Palmela","year":"2018","journal-title":"Gut"},{"key":"2026032500120364900_jjag006-B11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.immuni.2018.12.015","article-title":"Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and ROR\u03b3t+ regulatory T cells and exacerbate colitis in mice","volume":"50","author":"Britton","year":"2019","journal-title":"Immunity"},{"key":"2026032500120364900_jjag006-B12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"2026032500120364900_jjag006-B13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"2026032500120364900_jjag006-B14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"key":"2026032500120364900_jjag006-B15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"2026032500120364900_jjag006-B16","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3390\/jcm10132753","article-title":"Fecal microbial transplantation versus mesalamine enema for treatment of active left-sided ulcerative colitis\u2014results of a randomized controlled trial","volume":"10","author":"B\u0159ezina","year":"2021","journal-title":"J Clin Med"},{"key":"2026032500120364900_jjag006-B17","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","article-title":"Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet\u00a0al.ne is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial","volume":"71","author":"Kedia","year":"2022","journal-title":"Gut"},{"key":"2026032500120364900_jjag006-B18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","article-title":"Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Haifer","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026032500120364900_jjag006-B19","doi-asserted-by":"crossref","first-page":"1049849","DOI":"10.3389\/fmed.2022.1049849","article-title":"Efficacy and safety of fecal microbiota transplantation via colonoscopy as add-on therapy in patients with mild-to-moderate ulcerative colitis: a randomized clinical trial","volume":"9","author":"Tkach","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2026032500120364900_jjag006-B20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/ibd\/izac135","article-title":"Efficacy of fecal microbiota transplantation in the treatment of active ulcerative colitis: a systematic review and meta-analysis of double-blind randomized controlled trials","volume":"29","author":"El Hage Chehade","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2026032500120364900_jjag006-B21","doi-asserted-by":"crossref","first-page":"1756284819891038","DOI":"10.1177\/1756284819891038","article-title":"Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease","volume":"12","author":"Yalchin","year":"2019","journal-title":"Ther Adv Gastroenterol"},{"key":"2026032500120364900_jjag006-B22","doi-asserted-by":"crossref","first-page":"104088","DOI":"10.1016\/j.ebiom.2022.104088","article-title":"Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis","volume":"81","author":"Rees","year":"2022","journal-title":"EBioMedicine"},{"key":"2026032500120364900_jjag006-B23","doi-asserted-by":"crossref","first-page":"e030659","DOI":"10.1136\/bmjopen-2019-030659","article-title":"STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis","volume":"9","author":"Quraishi","year":"2019","journal-title":"BMJ Open"},{"key":"2026032500120364900_jjag006-B24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1079\/PHN2000102","article-title":"Nutritional methods in the European Prospective Investigation of Cancer in Norfolk","volume":"4","author":"Bingham","year":"2001","journal-title":"Public Health Nutr"},{"key":"2026032500120364900_jjag006-B25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"key":"2026032500120364900_jjag006-B26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4161\/gmic.28572","article-title":"Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia","volume":"5","author":"Narushima","year":"2014","journal-title":"Gut Microbes"},{"key":"2026032500120364900_jjag006-B27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science"},{"key":"2026032500120364900_jjag006-B28","doi-asserted-by":"crossref","first-page":"21536","DOI":"10.1073\/pnas.1922189117","article-title":"Defined microbiota transplant restores Th17\/ROR\u03b3t+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas","volume":"117","author":"Britton","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026032500120364900_jjag006-B29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12967-024-05122-w","article-title":"Short-chain fatty acid-producing bacterial strains attenuate experimental ulcerative colitis by promoting M2 macrophage polarization via JAK\/STAT3\/FOXO3 axis inactivation","volume":"22","author":"Zhao","year":"2024","journal-title":"J Transl Med"},{"key":"2026032500120364900_jjag006-B30","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis","volume":"156","author":"Paramsothy","year":"2019","journal-title":"Gastroenterology"},{"key":"2026032500120364900_jjag006-B31","doi-asserted-by":"crossref","first-page":"103293","DOI":"10.1016\/j.ebiom.2021.103293","article-title":"Short chain fatty acids and its producing organisms: an overlooked therapy for IBD?","volume":"66","author":"Deleu","year":"2021","journal-title":"EBioMedicine"},{"key":"2026032500120364900_jjag006-B32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-immunol-090222-102035","article-title":"Microbial metabolites and gut immunology","volume":"42","author":"Takeuchi","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"2026032500120364900_jjag006-B33","doi-asserted-by":"crossref","first-page":"e00049-23","DOI":"10.1128\/spectrum.00049-23","article-title":"Engineered bacteria for short-chain-fatty-acid-repressed expression of biotherapeutic molecules","volume":"11","author":"Serebrinsky-Duek","year":"2023","journal-title":"Microbiol Spectr"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjag006\/66579342\/jjag006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/3\/jjag006\/66579342\/jjag006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/3\/jjag006\/66579342\/jjag006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:12:13Z","timestamp":1774411933000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjag006\/8441229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjag006","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,1,23]]},"article-number":"jjag006"}}